Mohamad Makhzoumi

Mohamad first joined NEA as an associate in 2000 and now co-heads the healthcare services and healthcare information technology investment practice. Mohamad is currently a Director of American Pathology Partners, DaVita NephroLife, DSI Renal, Elements Behavioral Health, Nova Medical Centers, Radiology Partners, SCI Solutions and Simplex Healthcare. He is a Board Observer of BENU, Vantage Oncology and Welltok. Mohamad’s past investments include Bravo Health, CHG Healthcare, Long Term Care Group and ppoNEXT. Previously, Mohamad focused on growth equity investments at Summit Partners prior to which he worked with UBS Investment Bank where he concentrated on leveraged finance and sponsor-led transactions. Mohamad received a bachelor's degree, with distinction, from the University of Pennsylvania and is an active participant in the cancer community having been a founding board member of Livestrong’s Young Leadership Cancer Council.